1.	A Study of Advanced or Metastatic Non-small Cell Lung Cancer Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 12092, I2I-MC-JMMD, NCT00988858
2.	C14 Study in Oncology Patients With Advanced and/or Metastatic Solid Tumors Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13525, I2I-MC-JMMH, NCT01296568
3.	A Study of LY2603618 in Combination With Gemcitabine in Patients With Solid Tumors Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 20 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13574, I2I-JE-JMME, NCT01341457
4.	A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pathway of Desipramine Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13526, I2I-MC-JMMI, NCT01358968